Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
about
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysisVaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimensHuman papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic reviewA survey of population-based utility scores for cervical cancer preventionEffect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-VaccinationNew insights into cervical cancer screening.Long-term outcomes of high-risk human papillomavirus infection support a long interval of cervical cancer screening.Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.Human papillomavirus testing for primary cervical cancer screening.A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example.The road ahead for cervical cancer prevention and control.Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial.Brief research report: uncertainty-inducing and reassuring facts about HPV: a descriptive study of French Canadian women.HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16.Measures of test performance for high-risk HPV tests and triage cytology and the importance of follow-up of women with positive test results.Comparative study of the cervista and hybrid capture 2 methods in detecting high-risk human papillomavirus in cervical lesions.Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years.The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: a randomised controlled study.Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women.Characterization of human papillomavirus infection in north Taiwan.Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis
P2860
Q30878077-16ED98C2-62D4-4FDD-86ED-759431814701Q33545461-DEF98844-41AF-4B49-AB2D-99BED54B9997Q34011249-4898EECD-817B-4495-A3D9-1EC9B88B505AQ34806423-BE49C5C3-6E6C-407F-B849-D2C02C26A014Q34964786-6E2AAB52-7D1D-453F-86FA-CE4D724762C3Q34997580-C63B2CE6-CB11-4382-9050-3D267718998EQ35018648-19C38A93-9A10-4122-A498-6F378AA6EA68Q35659157-52CCDBF9-5B4F-44B7-8AF3-80EFE73665AFQ36231336-2BD27EF6-3203-4F4E-8CD2-14E21C9E6D1EQ36313296-BA8A0D97-67B3-41FD-A129-1AB677012860Q36494175-C3575356-530E-4720-8150-C5F3816D0BD8Q36813303-598ACAFA-2E44-4504-AE54-68928836C657Q36817519-30703C2B-C7F2-4B65-9361-14691D182FB5Q36839786-67D840A1-CF2D-4702-9D35-97D5FA4AF498Q37266480-CFF4B58A-5296-4747-81D8-6F4E13380918Q37625034-11DBB780-2D36-404C-981C-4B183CE5162CQ37719631-BDBD3FE1-CB09-4F0B-AE62-2AC8B80C5081Q39477130-32F1A1BB-2530-4B68-9311-7CD7D75CE6F0Q39948348-4B225B09-8CD2-4979-9583-19CA5B9928B2Q40673772-5134903C-EB50-4F13-BE20-910B1AA6BE98Q42190856-F7E6AA80-B8B7-41B5-92E4-996F074953FCQ42205199-609A6AAA-2B9E-4BE4-8F2C-8EBB794C72E3Q42279932-B51829BD-8571-467C-BCD0-AEEC26A93EC7Q42709627-02DF86B2-B5BC-4491-99D9-FB547A479160Q43588378-AFFDC4A1-AAA8-4E5A-B1E6-6968E97939C2Q44779725-1453BA54-166B-4840-BA6A-83D176A5A2D8Q47319540-73A5AFB0-D89E-4938-ACD9-D2400505CFC8Q54422907-5AD6F31E-0776-4CDE-BF2B-CB02B804193AQ57089346-F9673375-0BB0-4F8A-98F3-850282FA9CD1
P2860
Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@en
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@nl
type
label
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@en
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@nl
prefLabel
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@en
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@nl
P2093
P356
P1476
Randomized controlled trial of ...... ncer screening trial (CCCaST).
@en
P2093
CCCaST Study Group
Eliane Duarte-Franco
François Coutlée
Isabel Rodrigues
Marie-Hélène Mayrand
Sam Ratnam
Stephen D Walter
P304
P356
10.1002/IJC.21897
P577
2006-08-01T00:00:00Z